\n<\/p>\n
Mordor Intelligence has published a new report on\u00a0Porcine Vaccine Market, offering a comprehensive analysis of trends, growth drivers, and future projections.<\/span><\/b>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Introduction: Porcine Vaccine Market Overview<\/span><\/b>\u00a0<\/span><\/p>\n The\u00a0<\/span>Porcine Vaccines Market size<\/span><\/a>\u00a0is\u00a0valued\u00a0at USD 2.78 billion in 2026, and is expected to reach USD 4.73 billion by 2031, at a CAGR of 11.21% during the forecast period (2026-2031).\u00a0According to Mordor Intelligence, the porcine vaccine market size in the introductory phase of the forecast reflects steady demand from intensive pig farming operations and veterinary health programs. Vaccination\u00a0remains\u00a0a primary approach for managing infectious diseases in pigs, helping reduce mortality, improve feed efficiency, and support consistent meat supply.<\/span>\u00a0<\/span><\/p>\n Growth in the porcine vaccine\u00a0industry\u00a0is\u00a0closely linked\u00a0to rising pork consumption, increasing farm-level awareness of disease control, and the expansion of organized swine farming. Governments and industry bodies continue to emphasize preventive animal healthcare, which supports stable porcine vaccine market growth. The porcine vaccine market share is distributed across regions with high pork production, supported by veterinary service networks and established vaccination schedules.<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Porcine Vaccine Market\u00a0Trends<\/span><\/b>\u00a0<\/span><\/p>\n Rising Focus on Preventive Disease Management<\/span><\/b> Increased Commercialization of Swine Farming<\/span><\/b> Continued Use of Multivalent Vaccines<\/span><\/b> Veterinary Guidance Driving Vaccine Adoption<\/span><\/b> Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:\u00a0<\/span><\/b>https:\/\/www.mordorintelligence.com\/ja\/industry-reports\/porcine-vaccine-market?utm_source=emailwire<\/span><\/b><\/a>\u00a0<\/span><\/p>\n Porcine Vaccine Market Segmentation<\/span><\/b>\u00a0<\/span><\/p>\n The porcine vaccine market is segmented by vaccine type, disease\u00a0indication, and end user, reflecting diverse production systems and herd management practices.<\/span>\u00a0<\/span><\/p>\n By Disease Type<\/span><\/b>\u00a0<\/span><\/p>\n Porcine reproductive and respiratory syndrome<\/span> By Technology Platform<\/span><\/b>\u00a0<\/span><\/p>\n Live-attenuated<\/span> By Product Formulation<\/span><\/b>\u00a0<\/span><\/p>\n Monovalent vaccines<\/span> By Administration Route<\/span><\/b>\u00a0<\/span><\/p>\n Intramuscular<\/span> By Distribution Channel<\/span><\/b>\u00a0<\/span><\/p>\n Veterinary hospitals<\/span> \u00a0<\/span><\/p>\n These segments contribute differently to porcine vaccine market size and adoption depending on regional farming practices.<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Porcine Vaccine Market\u00a0Competitive Landscape\u00a0<\/span><\/b>\u00a0<\/span><\/p>\n The porcine vaccine\u00a0industry\u00a0includes global animal health companies and regional veterinary vaccine manufacturers. Key players focus on\u00a0maintaining\u00a0product availability, regulatory compliance, and strong distribution channels to reach commercial farms and veterinary practices.<\/span>\u00a0<\/span><\/p>\n Conclusion: Outlook for the Porcine Vaccine Market<\/span><\/b>\u00a0<\/span><\/p>\n The porcine vaccine market is expected to\u00a0maintain\u00a0stable growth throughout the forecast period as disease prevention\u00a0remains\u00a0a priority in swine production. Continued expansion of organized farming, rising awareness of herd health management, and reliance on vaccination schedules support long-term porcine vaccine market growth.<\/span>\u00a0<\/span><\/p>\n Industry related Reports:<\/span><\/b>\u00a0<\/span><\/p>\n Canine Vaccine Market<\/span><\/b>\u00a0<\/span><\/p>\n The canine vaccine market is expected to grow from USD 2.14 billion in 2025 to USD 2.27 billion in 2026 and is forecast to reach USD 3.06 billion by 2031 at a CAGR of 6.18% over 2026\u20132031, driven by rising pet ownership, greater preventive veterinary care adoption, and expansion of routine immunization programs.<\/span> \u00a0<\/span><\/p>\n Livestock Vaccines Market<\/span><\/b>\u00a0<\/span><\/p>\n The livestock vaccines market is projected to increase from USD 6.13 billion in 2025 to USD 6.37 billion in 2026 and is forecast to reach USD 7.72 billion by 2031 at a CAGR of 3.92% over 2026\u20132031, supported by growing demand for animal protein, focus on animal health, and expanding commercial livestock operations.<\/span> \u00a0<\/span><\/p>\n Poultry Vaccine Market<\/span><\/b>\u00a0<\/span><\/p>\n The poultry vaccine market was valued at USD 2.29 billion in 2025 and is estimated to grow from USD 2.49 billion in 2026 to reach USD 3.82 billion by 2031 at a CAGR of 8.92% during the forecast period, driven by rising poultry production, increased disease prevention measures, and broader adoption of vaccination protocols in commercial farms.<\/span>\u00a0<\/span><\/p>\n Report Overview:\u00a0<\/span>https:\/\/www.mordorintelligence.com\/industry-reports\/poultry-vaccines-market?utm_source=emailwire<\/span><\/a>\u00a0<\/span><\/p>\n About Mordor Intelligence:<\/span><\/b>\u00a0<\/span><\/p>\n Mordor Intelligence is a trusted partner for businesses\u00a0seeking\u00a0comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.<\/span>\u00a0<\/span><\/p>\n With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence\u00a0possesses\u00a0a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.<\/span>\u00a0<\/span><\/p>\n For any inquiries or to access the full report, please contact:<\/span><\/b>\u00a0<\/span><\/p>\n media@mordorintelligence.com<\/span><\/a>
\nOne of the most consistent porcine vaccine market trends is the growing emphasis on prevention rather than treatment. Swine producers increasingly rely on vaccination programs to manage diseases that can\u00a0impact\u00a0herd productivity and farm profitability. This approach supports sustained demand for routine porcine vaccines.<\/span>\u00a0<\/span><\/p>\n
\nThe shift from small-scale farms to organized commercial operations has strengthened demand for structured vaccination schedules. Large farms adopt standardized health management practices, which contributes to predictable purchasing patterns and supports porcine vaccine market analysis focused on long-term demand.<\/span>\u00a0<\/span><\/p>\n
\nMultivalent vaccines that protect against multiple pathogens are widely used in pig herds to reduce handling stress and simplify vaccination programs. This trend supports porcine vaccine market growth by improving compliance and operational efficiency at the farm level.<\/span>\u00a0<\/span><\/p>\n
\nVeterinarians play a key role in recommending vaccination protocols based on regional disease prevalence. Their involvement ensures consistent vaccine use across breeding, growing, and finishing stages, reinforcing porcine vaccine market share across production cycles.<\/span>\u00a0<\/span><\/p>\n
\nPorcine circovirus associated disease<\/span>
\nDiarrheal diseases<\/span>
\nSwine influenza<\/span>
\nClassical and African swine fever<\/span>
\nOther\u00a0diseases<\/span>\u00a0<\/span><\/p>\n
\nInactivated\/killed<\/span>
\nToxoid and subunit<\/span>
\nRecombinant vector<\/span>
\nOther\u00a0technology platform<\/span>\u00a0<\/span><\/p>\n
\nMultivalent \/ combination<\/span>\u00a0<\/span><\/p>\n
\nIntradermal<\/span>
\nOral and intranasal mucosal<\/span>\u00a0<\/span><\/p>\n
\nVeterinary clinics<\/span>
\nOther\u00a0end users<\/span>\u00a0<\/span><\/p>\n\n
\n
\n
\n
\n
\nReport Overview:\u00a0<\/span>https:\/\/www.mordorintelligence.com\/industry-reports\/canine-vaccine-market?utm_source=emailwire<\/span><\/a>\u00a0<\/span><\/p>\n
\nReport Overview:\u00a0<\/span>https:\/\/www.mordorintelligence.com\/industry-reports\/livestock-vaccines?utm_source=emailwire<\/span><\/a>\u00a0<\/span><\/p>\n
\nhttps:\/\/www.mordorintelligence.com\/<\/span><\/a>\u00a0<\/span><\/p>\n<\/p><\/div>\n